A randomized, observer-blind, controlled phase III clinical trial assessing safety and immunological non-inferiority of Vi-diphtheria toxoid versus Vi-tetanus toxoid typhoid conjugate vaccine in healthy volunteers in eastern Nepal
Author:
Affiliation:
1. B P Koirala Institute of Health Sciences (BPKIHS), Dharan, Nepal
2. International Vaccine Institute (IVI), Seoul, Korea
Funder
Bill and Melinda Gates Foundation
Publisher
Informa UK Limited
Subject
Pharmacology,Immunology,Immunology and Allergy
Link
https://www.tandfonline.com/doi/pdf/10.1080/21645515.2023.2203634
Reference28 articles.
1. Incidence of typhoid and paratyphoid fever in Bangladesh, Nepal, and Pakistan: results of the Surveillance for Enteric Fever in Asia Project
2. Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial
3. Summary of the WHO position paper on typhoid vaccines: wHO position paper- March 2018 [Internet]. [accessed 2023 Feb 7]. https://cdn.who.int/media/docs/default-source/immunization/position_paper_documents/typhoid/pp-typhoid-2018-summary.pdf?sfvrsn=b2fe8d02_2.
4. Typhoid [Internet]. World Health Organization. World Health Organization; [accessed 2023 Feb 7]. https://www.who.int/news-room/fact-sheets/detail/typhoid#:~:text=WHO%20estimates%20the%20global%20typhoid children%20are%20at%20highest%20risk.
5. Geographical distribution of typhoid risk factors in low and middle income countries
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Safety and immunogenicity of Vi-diphtheria toxoid typhoid conjugate vaccine among children below 2 years: a systematic review and meta-analysis;Frontiers in Microbiology;2024-04-05
2. Typhoid Conjugate Vaccine: A Boon for Endemic Regions;Cureus;2024-03-19
3. Randomised controlled trials in child and adolescent health in 2023;Archives of Disease in Childhood;2023-07-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3